Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-13

Clinical Trial Update: Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial investigates cladribine with G-CSF and cytarabine as salvage therapy for relapsed/refractory acute lymphoblastic leukemia, status not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYTARABINE (CYTARABINE)
  • Cladribine (cladribine)
  • G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Lymphoblastic Leukemia | Phase 2, Phase 3 | Status: UNKNOWN